These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21795)

  • 1. Beta-adrenergic blockade, blood pressure, and the renin-angiotensin system.
    Gross F
    Eur J Clin Invest; 1977 Oct; 7(5):321-2. PubMed ID: 21795
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the renin-angiotensin system in the blood pressure rebound to sodium nitroprusside in the conscious rat.
    Abukhres MM; Ertel RJ; Dixit BN; Vollmer RR
    Eur J Pharmacol; 1979 Oct; 58(3):247-54. PubMed ID: 41720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Mode of action of beta-adrenergic receptor blocking drugs in hypertension.
    Oliver NW
    Scott Med J; 1974 Jan; 19(1):43-4. PubMed ID: 4150625
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: When to measure renin.
    Lancet; 1975 Apr; 1(7910):783-4. PubMed ID: 48006
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 7. Renin and beta-adenoceptor blockade-the mechanism of the hypotensive effect?
    Hamer J
    Br J Clin Pharmacol; 1976 Jun; 3(3):425-7. PubMed ID: 9962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renin, angiotensin II, catecholamines and blood pressure in healthy subjects and in patients with essential hypertension prior and following beta-blockade].
    Schuchard J; Dahlheim H; Wober W; Grill G; Lydtin H; Thurau K
    Verh Dtsch Ges Inn Med; 1974; 80():215-8. PubMed ID: 4156113
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal effects of beta-adrenoceptor blockade.
    Weber MA; Drayer JI
    Kidney Int; 1980 Nov; 18(5):686-99. PubMed ID: 6109787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood pressure, renin, angiotension II and catecholamines in the plasma of healthy subjects and patients with essential hypertension before and after beta blockade].
    Schuchard J; Wober W; Dahlheim H; Thurau K; Lydtin H
    Adv Clin Pharmacol; 1976; 11():61-5. PubMed ID: 25570
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure.
    Davies DL; Beevers DG; Briggs JD; Medina AM; Robertson JI; Schalekamp MA; Brown JJ; Lever AF; Morton JJ; Tree M
    Lancet; 1973 Mar; 1(7805):683-6. PubMed ID: 4120488
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
    Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
    Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renin and age, determinants of the beta-blocker effect in essential hypertension].
    Bühler FR
    Adv Clin Pharmacol; 1976; 11():42-53. PubMed ID: 25569
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension].
    Stumpe KO; Vetter H; Hessenbroch V; Kolloch R; Düsing R; Krück F
    Verh Dtsch Ges Inn Med; 1975; 81():1038-41. PubMed ID: 7048
    [No Abstract]   [Full Text] [Related]  

  • 17. Renin and angiotensin.
    Lancet; 1968 Aug; 2(7563):335-6. PubMed ID: 4173742
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why use angiotensin converting enzyme inhibitors to lower blood pressure?
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S92-7. PubMed ID: 2412021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of beta-blockers on plasma renin activity. Present status].
    Plouin PF; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2769-74. PubMed ID: 30961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.